Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Douglas Corley and Jessica Chubak.
Connection Strength

3.947
  1. Incidence of serious complications following screening colonoscopy in adults aged 76 to 85 years old. Cancer Epidemiol Biomarkers Prev. 2024 Nov 25.
    View in: PubMed
    Score: 0.249
  2. Predicting Risk of Colorectal Cancer After Adenoma Removal in a Large Community-Based Setting. Am J Gastroenterol. 2024 Apr 11.
    View in: PubMed
    Score: 0.239
  3. Surveillance Colonoscopy Findings in Older Adults With a History of Colorectal Adenomas. JAMA Netw Open. 2024 Apr 01; 7(4):e244611.
    View in: PubMed
    Score: 0.238
  4. Risk of colorectal cancer and colorectal cancer mortality beginning one year after a negative fecal occult blood test, among screen-eligible 76-85-year-olds. Cancer Epidemiol Biomarkers Prev. 2023 Jul 14.
    View in: PubMed
    Score: 0.227
  5. Evaluating Different Approaches for Calculating Adenoma Detection Rate: Is Screening Colonoscopy the Gold Standard? Gastroenterology. 2023 09; 165(3):784-787.e4.
    View in: PubMed
    Score: 0.225
  6. Test performance metrics for breast, cervical, colon and lung cancer screening: a systematic review. J Natl Cancer Inst. 2023 Feb 08.
    View in: PubMed
    Score: 0.220
  7. Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years Old. Cancer Epidemiol Biomarkers Prev. 2023 01 09; 32(1):37-45.
    View in: PubMed
    Score: 0.219
  8. Informative Presence in Electronic Health Record Data: A Challenge in Implementing Study Exclusion Criteria. Epidemiology. 2023 Jan 01; 34(1):29-32.
    View in: PubMed
    Score: 0.214
  9. Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1517-1520.
    View in: PubMed
    Score: 0.212
  10. Association of Physician Adenoma Detection Rates With Postcolonoscopy Colorectal Cancer. JAMA. 2022 06 07; 327(21):2114-2122.
    View in: PubMed
    Score: 0.210
  11. Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems. Cancer Prev Res (Phila). 2020 11; 13(11):947-958.
    View in: PubMed
    Score: 0.184
  12. ANALYSES OF PREVENTIVE CARE MEASURES WITH INCOMPLETE HISTORICAL DATA IN ELECTRONIC MEDICAL RECORDS: AN EXAMPLE FROM COLORECTAL CANCER SCREENING. Ann Appl Stat. 2020 Jun; 14(2):1030-1044.
    View in: PubMed
    Score: 0.184
  13. Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. Gastroenterology. 2020 03; 158(4):884-894.e5.
    View in: PubMed
    Score: 0.174
  14. Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems. Cancer Epidemiol Biomarkers Prev. 2019 Jan; 28(1):91-98.
    View in: PubMed
    Score: 0.164
  15. Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study. Ann Intern Med. 2018 Oct 02; 169(7):439-447.
    View in: PubMed
    Score: 0.162
  16. Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiol Biomarkers Prev. 2016 Feb; 25(2):344-50.
    View in: PubMed
    Score: 0.135
  17. Association between racial residential segregation and screening uptake for colorectal and cervical cancer among Black and White patients in five US health care systems. Cancer. 2024 Aug 09.
    View in: PubMed
    Score: 0.061
  18. Provider- and Facility-Level Variation in Pre-Cancerous Cervical Biopsy Diagnoses. J Low Genit Tract Dis. 2023 Jan 17.
    View in: PubMed
    Score: 0.055
  19. Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines. Ann Intern Med. 2022 11; 175(11):1582-1590.
    View in: PubMed
    Score: 0.054
  20. Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings. Cancer Med. 2023 Feb; 12(3):3705-3717.
    View in: PubMed
    Score: 0.054
  21. Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1521-1531.
    View in: PubMed
    Score: 0.053
  22. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium. J Natl Cancer Inst. 2020 03 01; 112(3):238-246.
    View in: PubMed
    Score: 0.045
  23. Colonoscopy Indication Algorithm Performance Across Diverse Health Care Systems in the PROSPR Consortium. EGEMS (Wash DC). 2019 Aug 02; 7(1):37.
    View in: PubMed
    Score: 0.043
  24. Treatment patterns and survival differ between early-onset and late-onset colorectal cancer patients: the patient outcomes to advance learning network. Cancer Causes Control. 2019 Jul; 30(7):747-755.
    View in: PubMed
    Score: 0.042
  25. Time to Follow-up After Colorectal Cancer Screening by Health Insurance Type. Am J Prev Med. 2019 May; 56(5):e143-e152.
    View in: PubMed
    Score: 0.042
  26. Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort. Int J Cancer. 2019 Mar 15; 144(6):1460-1473.
    View in: PubMed
    Score: 0.041
  27. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States. Am J Gastroenterol. 2018 May; 113(5):746-754.
    View in: PubMed
    Score: 0.039
  28. Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly. Am J Prev Med. 2016 09; 51(3):e67-75.
    View in: PubMed
    Score: 0.035
  29. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach. J Gen Intern Med. 2016 10; 31(10):1190-7.
    View in: PubMed
    Score: 0.035
  30. Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems. Am J Prev Med. 2016 10; 51(4):e107-15.
    View in: PubMed
    Score: 0.034
  31. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1147-58.
    View in: PubMed
    Score: 0.030
  32. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):312-20.
    View in: PubMed
    Score: 0.028

© 2024 Kaiser Permanente